Antibody-targeted liposomes in cancer therapy and imaging (Q37076367)

18 August 2017

1 reference

title

Antibody-targeted liposomes in cancer therapy and imaging (English)

1 reference

18 August 2017

1 reference

George Sgouros

1 reference

18 August 2017

Stavroula Sofou

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

Expert Opinion on Drug Delivery

18 August 2017

published in

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

page(s)

189-204

1 reference

Immunoliposome labeling: a sensitive and specific method for cell surface labeling

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Interactions of liposomes with cells in vitro and in vivo: opsonins and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Homing of liposomes to target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

By-passing of P-glycoprotein using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Differential endocytosis of T and B lymphocyte surface molecules evaluated with antibody-bearing fluorescent liposomes containing methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Monoclonal antibody covalently coupled to liposomes: specific targeting to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Ligand-targeted liposomes for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Ligand-targeted therapeutics in anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Serum independent liposome uptake by mouse liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

21 January 2018

Liposome opsonization

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Measurements of interbilayer forces and protein adsorption on uncharged lipid bilayers displaying poly(ethylene glycol) chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Enhanced retention of the alpha-particle-emitting daughters of Actinium-225 by liposome carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Biodistribution and pharmacokinetics of 111In-dTPA-labelled pegylated liposomes after intraperitoneal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Preclinical manufacture of anti-HER2 liposome-inserting, scFv-PEG-lipid conjugate. 2. Conjugate micelle identity, purity, stability, and potency analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Catecholamine uptake and concentration by liposomes maintaining pH gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Immunoliposomes for the targeted delivery of antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Noninvasive gene targeting to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Antibody targeted gene transfer to endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Binding and interstitial penetration of liposomes within avascular tumor spheroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Polymeric contrast agents for medical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Tumor angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Membrane fusion plays an important role in gene transfection mediated by cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Higly fusogenic cationic liposomes transiently permeabilize the plasma membrane of HeLa cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.2.189

21 January 2018

Identifiers

DOI

10.1517/17425247.5.2.189

1 reference

18 August 2017

1 reference